Vericel Corp Ord (VCEL)
Total asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 197,516 | 164,365 | 156,184 | 124,179 | 117,850 |
Total assets | US$ in thousands | 353,657 | 273,003 | 243,705 | 205,608 | 153,238 |
Total asset turnover | 0.56 | 0.60 | 0.64 | 0.60 | 0.77 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $197,516K ÷ $353,657K
= 0.56
Vericel Corp's total asset turnover has shown a declining trend over the past five years, from 0.77 in 2019 to 0.56 in 2023. This ratio indicates the company's efficiency in generating sales from its total assets. A lower total asset turnover could suggest that the company is not effectively utilizing its assets to generate revenue. It may be a sign of inefficient asset management or declining sales relative to its asset base. Vericel Corp should focus on improving its asset utilization efficiency to enhance its overall financial performance and profitability.
Peer comparison
Dec 31, 2023
Company name
Symbol
Total asset turnover
Vericel Corp Ord
VCEL
0.56
Amgen Inc
AMGN
0.26
Bio-Techne Corp
TECH
0.43
Biogen Inc
BIIB
0.37
Gilead Sciences Inc
GILD
0.42
Halozyme Therapeutics Inc
HALO
0.47
Krystal Biotech Inc
KRYS
0.07
Moderna Inc
MRNA
0.37
Neurocrine Biosciences Inc
NBIX
0.58
Regenxbio Inc
RGNX
0.15
Repligen Corporation
RGEN
0.22